Distinguished in AIDS Dysmorphic Syndrome

Dr. Edgar T. Overton

Infectious Disease
University Of Alabama Health Services Foundation, PC
619 19th St S, 
Birmingham, AL 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
26 Years of Experience
Distinguished in AIDS Dysmorphic Syndrome
University Of Alabama Health Services Foundation, PC
619 19th St S, 
Birmingham, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Edgar Overton is an Infectious Disease provider in Birmingham, Alabama. Dr. Overton has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Overton is currently accepting new patients.

His clinical research consists of co-authoring 183 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Infectious Disease
Licenses
Internal Medicine in AL
Hospital Affiliations
University Of Alabama Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION, PC
619 19th St S, Birmingham, AL 35249

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Nonalcoholic Fatty Liver Disease In Persons Living With HIV Database Study
Nonalcoholic Fatty Liver Disease In Persons Living With HIV Database Study
Enrollment Status: Recruiting
Publish Date: September 05, 2025
A Proof-of Concept, Randomized, Controlled Study of Tuberculosis Immunization With BCG to Prevent Infection in Healthy Adults (TIPI Trial)
A Proof-of Concept, Randomized, Controlled Study of Tuberculosis Immunization With BCG to Prevent Infection in Healthy Adults (TIPI Trial)
Enrollment Status: Recruiting
Publish Date: May 22, 2025
Intervention Type: Drug, Biological
Study Phase: Phase 3
Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses
Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses
Enrollment Status: Completed
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drug: Elvitegravir+Cobicistat+Emtricitabine+Tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
Study Phase: Phase 2
Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial
Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Biological, Other, Procedure
Study Drug: Recombinant Human Papillomavirus Nonavalent Vaccine
Study Phase: Phase 2
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
Enrollment Status: Completed
Publish Date: December 04, 2024
Intervention Type: Other, Biological
Study Drugs: Quadrivalent Inactivated Influenza Vaccine, Trivalent Influenza Vaccine
Study Phase: Phase 2
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
Enrollment Status: Completed
Publish Date: October 28, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3b Multi-center, Open Label, Single Arm, 52-week Study, Evaluating the Feasibility, Efficacy and Safety of Rapid Test and Treat Intervention in Newly Diagnosed HIV-1 Infected Adults Using a Fixed Dose Combination of Dolutegravir Plus Lamivudine (DOVATO) as a First Line Regimen
A Phase 3b Multi-center, Open Label, Single Arm, 52-week Study, Evaluating the Feasibility, Efficacy and Safety of Rapid Test and Treat Intervention in Newly Diagnosed HIV-1 Infected Adults Using a Fixed Dose Combination of Dolutegravir Plus Lamivudine (DOVATO) as a First Line Regimen
Enrollment Status: Completed
Publish Date: October 21, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Multicenter Phase III Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of a Freeze-dried Formulation of MVA-BN® Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
A Randomized, Double-blind, Multicenter Phase III Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of a Freeze-dried Formulation of MVA-BN® Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Enrollment Status: Completed
Publish Date: May 27, 2021
Intervention Type: Biological
Study Phase: Phase 3
Safety, Tolerability, and Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-Infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study
Safety, Tolerability, and Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome and Immune Activation Markers in HIV-Infected Participants on Suppressive Antiretroviral Therapy: A Phase II Study
Enrollment Status: Completed
Publish Date: January 06, 2020
Intervention Type: Drug
Study Phase: Phase 2
Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and Antiretroviral Therapy (ART)
Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and Antiretroviral Therapy (ART)
Enrollment Status: Completed
Publish Date: June 06, 2018
Intervention Type: Device, Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

188 Total Publications

APOL1 Genotype and HIV Infection: 20-Year Outcomes for CKD, Cardiovascular Disease, and Hypertension.
APOL1 Genotype and HIV Infection: 20-Year Outcomes for CKD, Cardiovascular Disease, and Hypertension.
Journal: Kidney international reports
Published: October 22, 2024
Similar Doctors
Michael S. Saag
Distinguished in AIDS Dysmorphic Syndrome
Dr. Michael S. Saag
Infectious Disease
Distinguished in AIDS Dysmorphic Syndrome
Dr. Michael S. Saag
Infectious Disease

University Of Alabama Health Services Foundation, PC

619 19th St S, 
Birmingham, AL 
 (0.1 miles away)
205-934-4011
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Saag is an Infectious Disease provider in Birmingham, Alabama. Dr. Saag is rated as a Distinguished provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, and Myelitis. Dr. Saag is currently accepting new patients.

Advanced in AIDS Dysmorphic Syndrome
Dr. Jodie A. Dionne
Infectious Disease
Advanced in AIDS Dysmorphic Syndrome
Dr. Jodie A. Dionne
Infectious Disease

University Of Alabama Health Services Foundation, PC

1700 6th Ave S, Suite 9100, 
Birmingham, AL 
 (0.2 miles away)
205-934-3460
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jodie Dionne is an Infectious Disease provider in Birmingham, Alabama. Dr. Dionne is rated as a Distinguished provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. Her top areas of expertise are HIV/AIDS, Syphilis, Gonorrhea, and Myelitis. Dr. Dionne is currently accepting new patients.

Distinguished in AIDS Dysmorphic Syndrome
Dr. Barbara J. Hanna
Infectious Disease
Distinguished in AIDS Dysmorphic Syndrome
Dr. Barbara J. Hanna
Infectious Disease
608 Martin Luther King Dr, 
Hobson City, AL 
 (55.7 miles away)
256-832-0100
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Barbara Hanna is an Infectious Disease provider in Hobson City, Alabama. Dr. Hanna is rated as an Advanced provider by MediFind in the treatment of AIDS Dysmorphic Syndrome. Her top areas of expertise are Myelitis, AIDS Dysmorphic Syndrome, HIV/AIDS, and AIDS Dementia Complex. Dr. Hanna is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Overton's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile